#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Jason Hanson Email
CEO & Director . enGene
St-Laurent,
LocationPrimary Email
How to contact Jason Hanson
Join and see Jason's contact info for free!Current Roles
Employees:
78Revenue:
$12.1MAbout
enGene Inc. is a biotechnology company developing a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues. The dually derived chitosan (DDX) platform has a high-degree of payload flexibility including DNA and various forms of RNA (siRNA, shRNA, lncRNA etc.) with broad tissue and disease applications. In addition to developing EG-70 for BCG-unresponsive NMIBC, enGene enGene is developing unique genetic medicines for respiratory indications. The company is also evolving its technology to enable applications in several mucosal tissues such as the nasal and genital mucosa as well as the gastrointestinal tract among others. enGene is supported financially by top-tier institutional investors including Forbion Capital Partners, Fonds de Solidarité FTQ, Pharmstandard International S.A., Lumira Capital and Johnson & Johnson Development Corporation.enGene Address
4868 Rue LevySt-Laurent, null